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Abstract 
The role of p53 in apoptosis i  unclear: it is essential for the apoptotic response to certain stimuli, such as ionising radiation, but is not 
required for others, such as castration-induced prostatic atrophy. Various tumour cell lines that are without functioning p53 are enabled to 
undergo apoptosis by transfecting wild type 53. The regulation of p53 mRNA is determined here, in two in vivo models of apoptosis. The 
first is partial iver ischaemic atrophy due to distal portal vein ligation, and the second is unilateral hydronephrosis from ureteric ligation. 
Mild ischaemia nd elevated pressure, respectively, are thought o both cause mild cellular damage, induction of p53 and cell death by 
apoptosis. In both models of apoptosis, upregulation of p53 is shown. 
Keywords: Apoptosis; Liver ischaemic atrophy; Hydronephrosis; Tumor suppressor gene p53 
1. Introduction 
Apoptosis plays a fundamental role in cancer, A.I.D.S., 
embryogenesis and immunological tolerance. Unravelling 
the complex molecular control of apoptosis will greatly 
enhance our understanding of these very diverse processes. 
p53 is a tumour suppressor gene and mutations of this 
gene occur in over 60% of human malignancies. Partly 
how p53 mutations contribute to the tumor phenotype is by 
diminishing the ability of cells to undergo apoptosis when 
exposed to genotoxic agents [1]. When a normal cell is 
exposed to DNA damage, p53 levels rise. Cell cycle 
progression is stopped to allow time for repair of damaged 
DNA. If repair is not possible, the damaged cells are 
deleted by apoptosis. Cells with mutant p53 cannot un- 
dergo this arrest, with subsequent repair or elimination. 
Such cells then may accumulate mutations and become 
malignant [2]. Various types of cell and DNA damage 
induce p53 expression, with DNA strand breaks being the 
major factor. Ionising radiation and many chemotherapeu- 
tic drugs, such as Bleomycin induce p53 upregulation [3] 
and usually subsequent cell death by apoptosis. For apop- 
tosis produced by gamma irradiation there is an absolute 
requirement for functional p53. In p53 null mice, neither 
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apoptosis of thymocytes nor apoptosis of gastro-intestinal 
cells can occur with radiation injury [4-7]. 
The requirement for p53 expression in other more 
physiological models of apoptosis is less clearly defined. 
Induction of p53 mRNA associated with apoptosis has 
been shown in the brain after adrenalectomy [8] and after 
excitotoxic treatment [9]. Increased expression has also 
been shown with apoptosis of antral ovarian follicles in the 
rat [10]. Dexamethasone-induced apoptosis of thymocytes 
and apoptosis in the prostate secondary to castration can 
proceed unchecked in p53 null mice [11]. Whether p53 is 
involved in co-ordinating the response of tissues to mild 
injury is unclear at present. This study investigated p53 
mRNA expression in two disparate models of mild cellular 
injury, both of which also produce apoptosis. The first 
model is mild ischaemia in the rat liver, while in the 
second there is cell loss in the rat kidney due to raised 
pressure, with associated ischaemia. 
In the liver, there is marked atrophy of the left and 
median lobes, occurring over a few days, secondary to 
portal vein branch ligation [12]. The affected lobes do not 
undergo infarction with necrosis, as the liver has a dual 
blood supply and the hepatic arterial flow to these lobes 
helps support issue viability. However, many hepatocytes 
suffer less severe injury and die by apoptosis, resulting in 
dramatic shrinkage of the affected lobes. Compensatory 
hyperplasia of the non-ischaemic lobes occurs. In the 
second model, hydronephrosis due to ureteric ligation, 
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there is progressive atrophy of the kidney [13]. The atro- 
phy (effected by apoptosis of tubular epithelial cells) is 
partly a consequence of the associated ischaemia occurring 
in this model [14]. Mechanical factors, with a direct pres- 
sure effect on the tubules from accumulated urine, are also 
thought o cause cellular damage [15]. It is shown here that 
p53 mRNA is upregulated in both mild hepatic ischaemia- 
associated apoptosis and pressure-induced apoptosis in the 
kidney. 
2. Materials and methods 
2.1. Animals 
Outbred male Sprague-Dawley rats weighing 250 (_+ 25) 
g were used. They had free access to water and to a 
standard pelleted iet. The animals were anaesthetised with 
intraperitoneal sodium pentobarbitone, 50 mg/kg body 
weight for the kidney experiments, and with intraperitoneal 
Ketamine hydrochloride 80 mg/kg and Xylazine hydro- 
chloride 12 mg/kg for the liver experiments. The ab- 
domen was entered using a midline incision. Atrophy of 
the left and median lobes of the rat liver was produced as 
described [12] with ligation of the portal vein branch to the 
left and median lobes with 4-0 silk. Hydronephrosis was 
produced by ligating the left ureter with 4-0 silk at 1 cm 
below the renal pelvis in treated rats [13]. All animals were 
killed by an overdose of sodium pentobarbitone up to 14 
days after surgery. At least three animals were studied at 
each time point. Control animals were sacrificed without 
prior surgery. Livers were collected at 0, 2, 3, 5, 7 and 14 
days and kidneys were collected at 0, 1, 2, 3, 7 and 14 
days, time 0 days representing control animals. 
2.2. Tissues 
The liver or kidneys were collected and dealt with in 3 
ways: (1) representative tissue was thinly sliced and fixed 
in 4% buffered neutral formalin for subsequent histological 
examination; (2) 1 mm thick sections were taken and fixed 
in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.2) for electron microscopic examination; (3) the 
remaining tissue was snap-frozen in liquid nitrogen for 
later RNA extraction. For light microscopic study, 4-/zm 
paraffin sections were stained with haematoxylin a d eosin. 
For electron microscopy, blocks of 1 mm 3 in size were 
post-fixed in osmium tetroxide and stained with uranyl 
acetate. Thick sections (1 /zm) were stained with toluidine 
blue, and ultrathin sections from selected areas were stained 
with lead citrate for later examination. Using light mi- 
croscopy, the number of cells undergoing apoptosis or 
mitosis was counted using a 100 × objective with oil 
immersion and this number expressed as a percentage of 
total cells counted. Hepatocytes only were counted in the 
liver and tubular epithelial cells only were counted in the 
kidney. Fields were selected randomly and at least 600 
cells were counted per slide. 
2.3. RNA extraction and Northern blots 
Total RNA was extracted using the guanidinium iso- 
thiocyanate and caesium chloride methods [16]. 20 /zg of 
total RNA was loaded in each lane and its integrity was 
checked with ultraviolet light illumination of ethidium 
bromide-stained gels. Northern blots were performed as 
described [17], the RNA being blotted onto Hybond N + 
nylon membranes (Amersham). A rat p53 cDNA probe 
was kindly supplied by Dr. T. Soussi, Institut de Genetique 
Moleculaire, Paris, France [18] and labelled with random 
priming using [32 P]dCTP (Amersham). Filters were probed 
at high stringency. Even loading of the RNA was deter- 
mined by stripping the filters and reprobing with an oligo- 
probe to the 18S component of ribosomal RNA. The 
relative level of RNA expression was determined using a 
phosphor imager and image quant software (Molecular 
Dynamics) for quantitation. Values were corrected for the 
amount of loading using ribosomal RNA. Three Northern 
blots were performed for the liver experiments and three 
Northern blots for the kidney experiments. 
3. Results 
3.1. Liver 
By 2-3 days post-surgery, atrophy of the left and 
median lobes of the liver was seen macroscopically. On 
histological examination, apoptotic bodies were identified 
by their characteristic appearance: round, small, 
eosinophilic ondensed cells with marginated and con- 
densed nuclear chromatin, the cells often being found in 
small aggregates (Fig. I) [19]. Ultrastructurally, typical 
membrane-bounded apoptotic bodies were identified (Fig. 
2). Apoptosis of hepatocytes was initially found approxi- 
mately midway between central veins and portal tracts, and 
Fig. 1. Left lobe of liver, after portal vein ligation, showing numerous 
apoptotic bodies (arrows) (haematoxylin and eosin stain). 
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Fig. 5. One representative Northern blot of livers in portal vein branch 
ligation, showing p53 above and rRNA below. 
Fig. 2. Ultrastructural ppearance of apoptotic body in the left lobe of the 
liver (bar = 2 /zm). 
with progressive atrophy, was found more frequently 
around central veins. Apoptotic bodies were most frequent 
at 2-3 days in the left lobe of the liver, where they 
comprised up to 25% of cells. Mitotic figures were less 
frequent. They were maximal at day 3 and were predomi- 
nantly in the fight lobe; only rare mitoses were identified 
in the left lobe (Figs. 3 and 4). The development of 
apoptosis in the liver, with treatment was highly signifi- 
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Fig. 6. Mean and standard error of the mean of p53 expression from 3 
Northern blots from livers with portal vein ligation. 
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Fig. 3. Frequency of apoptosis in the left and right lobes of the liver, 
showing the mean and the standard error of the mean (n = 3). 
cant, F = 41.28, P < 0.001, 1 d.f. [20]. A greater than 
two-fold increase in the steady-state l vel of p53 was seen 
in the left lobe of the liver compared with the fight lobe, 
with a peak on day three. This was statistically significant, 
using balanced ANOVA, F = 11.04, d.f. = 1 (P = 0.003). 
A representative Northern blot is shown in Fig. 5 and the 
mean values for three filters is shown in Fig. 6. 
3.2. Kidney 
Hydronephrosis of the left kidney was seen macroscopi- 
cally also by 2-3 days post-surgery. In the kidney, apop- 
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Fig. 4. Fequency of mitosis in the left and right lobes of the liver, 
showing the mean and the standard error of the mean (n = 3). 
Fig. 7. Left kidney, after ureteric ligation, showing occasional apoptotic 
bodies (arrows) (haematoxylin and eosin stain). 
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Fig. 11. One representative Northern blot of kidneys in hydronephrosis, 
showing p53 above and rRNA below. 
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Fig. 8. Ultrastructural ppearance of apoptotic body in the left kidney 
(bar = 2 p~m). 
totic bodies were identified almost solely in the renal 
tubules and these also displayed characteristic light micro- 
scopic (Fig. 7) and ultrastructural features (Fig. 8). Apop- 
tosis occurred later in the kidney than in the liver, and a 
lower proportion of apoptotic bodies was found. Apoptosis 
was still occurring at two weeks post-surgery. Infrequent 
mitoses were identified in the kidneys and they were 
maximal at days 2 and 3 and were found in the left (later 
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Fig. 12. Mean and standard error of the mean of p53 expression from 3 
Northern blots from kidneys with hydronephrosis. 
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Fig. 9. Frequency of apoptosis in the right and left kidneys, showing the 
mean and the standard error of the mean (n = 3). 
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Fig. 10. Frequency of mitosis in the right and left kidneys, showing the 
mean and the standard error of the mean (n = 3). 
apoptotic) kidney rather than in the right kidney (Figs. 9 
and 10). Apoptosis developing in the kidney was signifi- 
cant, F = 10.89, P < 0.001, 1 d.f. (balanced ANOVA). By 
day 2 after ureteric ligation there was also a greater than 
two-fold increase in p53 mRNA in the left kidney, com- 
pared with either that of the right kidney or with control, 
untreated kidney. Using balanced ANOVA, F = 42.72, 
d.f. = 1 (P <0.001). A representative Northern blot is 
shown in Fig. 11 and the mean values for three filters is 
shown in Fig. 12. 
4. Discussion 
The role of p53 mutations in tumorigenesis, and the 
p53-mediated cellular esponse to DNA damage, including 
cell cycle arrest and the induction of apoptosis, are major 
areas of current research (reviews in Refs. [21-23]). This 
paper describes the induction of p53 mRNA in two dis- 
parate models of mild cellular injury, both of which pro- 
duce apoptosis. 
The first model, hepatic atrophy secondary to portal 
vein ligation, is completed quickly with the major cellular 
changes occurring within two weeks. The affected lobes 
shrink in size and the unaffected lobes undergo compen- 
satory enlargement [12]. Cell loss in the affected lobes is 
due to apoptosis. Apoptosis peaks early and though still 
slightly elevated at two weeks after surgery, has almost 
returned to background levels by this time. p53 mRNA 
expression i creases by 150% above normal control values 
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and returns towards control levels as apoptosis decreases. 
That the peak of p53 mRNA occurs slightly later than the 
peak of apoptosis uggests that remaining sublethally in- 
jured hepatocytes, that have not undergone apoptosis, are 
contributing to the increased expression. With p53 up-reg- 
ulation, a cell cycle block occurs, to give cells time to 
undergo DNA repair. Some mildly damaged cells may 
have undergone repair rather than apoptotic ell death. 
In contrast o the situation in the liver, renal tissue loss 
with hydronephrosis evolves more slowly, occurring over 
several weeks. The frequency of apoptosis in the renal 
model peaks at less than 5% of the cells counted, com- 
pared with over 20% in the liver. Thus the cellular changes 
in the kidney occur at a slower rate. They also occur over a 
longer time course. In one study of experimental hydro- 
nephrosis, apoptotic figures were still detected at 6 -8  
weeks [13]. The present study shows an early, low peak of 
mitosis in the affected kidney, and then cell loss from the 
renal tubules by apoptosis, p53 mRNA is upregulated in 
the apoptotic kidney and this increased expression persists 
at two weeks, at a time when the frequency of apoptosis 
remains elevated above control levels. 
Specifically how mild ischaemia damages cells and 
causes them to die by apoptosis is not known; however, 
the induction of apoptosis by hypoxia has been shown in 
various tissues. Hypoxia-induced apoptosis has been shown 
in the nervous system with apoptosis of cells in the 
cingulate sulcus of newborn piglets after a global 
hypoxia-ischaemia insult [24], and also hypoxic injury to 
sympathetic neurons in culture produced later apoptosis 
[25]. Also, the human adenocarcinoma cell line HT29 
underwent apoptosis with exposure to hypoxic conditions 
[26] and, using a renal tubule epithelial cell line, oxidant 
injury activated endonucleases and caused cell death by 
apoptosis [27]. Oxidative stress has also shown to induce 
apoptosis of thymocytes [28]. 
Hypoxic tissue injury has also been associated with p53 
upregulation [27]. A likely explanation for why this occurs 
is that ischaemia is associated with the production of 
oxygen free radicals. Oxygen free radicals can cause DNA 
strand breaks and DNA strand breaks are the major in- 
ducer of p53 [29]. Hypoxic injury was associated with p53 
accumulation in a model of cerebral ischaemia [30], and 
also when various tumour cell lines were exposed to low 
oxygen conditions, p53 levels increased proportionate to 
the duration of hypoxia [31]. 
In summary, increased expression of p53 mRNA has 
been shown in two examples of mild injury induced 
apoptosis, one in the liver and one in the kidney, ls- 
chaemia is the mode of injury in the liver, with ischaemia 
as well as increased pressure causing cell damage in the 
kidney. Identifying the proximal stimuli to apoptosis which 
are associated with p53 upregulation will help clarify the 
exact role p53 plays in the control of this critical process. 
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